KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Diebold Nixdorf (DBD) Asset Writedowns and Impairment (2016 - 2024)

Diebold Nixdorf's Asset Writedowns and Impairment history spans 15 years, with the latest figure at $300000.0 for Q4 2024.

  • For Q4 2024, Asset Writedowns and Impairment changed N/A year-over-year to $300000.0; the TTM value through Dec 2024 reached $1.9 million, changed N/A, while the annual FY2024 figure was $1.9 million, N/A changed from the prior year.
  • Asset Writedowns and Impairment reached $300000.0 in Q4 2024 per DBD's latest filing, down from $1.6 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $55.2 million in Q1 2022 to a low of $300000.0 in Q3 2021.
  • Average Asset Writedowns and Impairment over 5 years is $9.5 million, with a median of $1.6 million recorded in 2024.
  • Peak YoY movement for Asset Writedowns and Impairment: soared 4610.0% in 2022, then plummeted 98.37% in 2023.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $800000.0 in 2020, then increased by 25.0% to $1.0 million in 2021, then skyrocketed by 4610.0% to $47.1 million in 2022, then crashed by 97.66% to $1.1 million in 2023, then tumbled by 72.73% to $300000.0 in 2024.
  • Per Business Quant, the three most recent readings for DBD's Asset Writedowns and Impairment are $300000.0 (Q4 2024), $1.6 million (Q3 2024), and $1.1 million (Q3 2023).